Print
	Email
	Text size
	Comment

Lab21, a Cambridge-based healthcare diagnostics company, has acquired Plasmatec Laboratory Products, a Dorset-based manufacturer and distributor of in vitro diagnostic tests.

The deal comes shortly after the acquisition of Biotec Laboratories. Graham Mullis, CEO of Lab21, commented: “Plasmatec will continue to be based in Dorset but there will be significant cross-selling opportunities within Lab21’s enlarged diagnostic products division. This acquisition follows the purchase earlier this year of Biotec Laboratories Ltd and underlines the momentum of our buy-and-build strategy.”

Martin Shaw, founder and managing director of Plasmatec, said: “Plasmatec is well placed to add to Lab21’s growing product portfolio and offers particular expertise in the Middle East and South American markets.”

Comments [0]